•  11/26/2020 09:11 AM

On November 24, 2020, the Food and Drug Administration granted accelerated approval to naxitamab (DANYELZA, Y-mAbs Therapeutics, Inc.) in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) for pediatric patients one year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow demonstrating a partial response, minor response, or stable disease to prior therapy.

Read More
  •  11/26/2020 07:19 AM

Scientists say a drug originally developed to treat high blood pressure can reduce severe withdrawal symptoms for patients diagnosed with alcohol use disorder.

Read More
  •  11/26/2020 07:00 AM

In the antiseptic world of drug manufacturing, cleanliness is key and outside contamination is a drugmaker’s worst enemy.

Read More
  •  11/26/2020 06:51 AM

Scientists have created a drug that can lure stem cells to damaged tissue and improve treatment efficacy -- a scientific first and major advance for the field of regenerative medicine.

Read More
  •  11/23/2020 12:38 AM

The U.S. Food and Drug Administration approved Zokinvy (lonafarnib) capsules to reduce the risk of death due to Hutchinson-Gilford progeria syndrome and for the treatment of certain processing-deficient progeroid laminopathies in patients one year of age and older.

Read More
  •  11/23/2020 12:12 AM

The prescription of potentially inappropriate medications to older adults is linked to increased hospitalizations, and it costs patients, on average, more than $450 per year, according to a new University at Buffalo study.

Read More
  •  11/20/2020 04:37 AM

MSD’s novel antibiotic treatment Recarbrio has launched in the UK as concerns grow over the rise of antimicrobial resistance (AMR) globally.

Read More
  •  11/20/2020 04:23 AM

Biotech companies here, including Samsung Biologics and Celltrion, will invest a combined 10 trillion won ($9.03 billion) by 2023 in line with President Moon Jae-in's initiative to make biotechnology a growth driver for Asia's fourth-largest economy. This comes in response to an administration initiative unveiled Wednesday to help these firms upgrade their structure for the manufacture and distribution of drugs and medical devices, and to hire more talented employees.

Read More
  •  11/19/2020 01:12 AM

Gland Pharma's ₹ 6,480 crores initial public offering (IPO) had received a muted response; It was subscribed by a mere 2.06 percent, receiving bids for 6,21,55,670 shares as against the issue size of 3,02,37,879 shares.

Read More
  •  11/19/2020 01:01 AM

The U.S. Food and Drug Administration is committed to transparency and keeping the public and stakeholders informed of our work upholding the safety of our food supply.

Read More
  •  11/19/2020 12:52 AM

Cipla has signed a licensing agreement with a Belgium-based firm, Multi G for the distribution of their COVID-19 rapid antibody test kit, across most Emerging markets and Europe.

Read More
  •  11/19/2020 12:42 AM

Pfizer Inc. said a final analysis of clinical-trial data showed its Covid-19 vaccine was 95% effective, paving the way for the company to apply for the first U.S. regulatory authorization for a coronavirus shot within days.

Read More